Introduction
Congestive heart failure is an important public health problem in developed countries' 121 . The progressive ageing of the population, along with increased survival of patients with ischaemic heart disease and/or high blood pressure, as a result of improvements in treatment, are likely to lead to an increase in the incidence of congestive heart failure in the coming years'
31
. Moreover, therapies with vasodilators and angiotensin converting enzyme inhibitors (ACEI) prolong congestive heart failure survival' 451 , something which could further contribute to increasing its prevalence in future.
The Framingham Heart Study reported an annual incidence of congestive heart failure of 2-3 cases per 1000 among males and 1-4 cases per 1000 among females' 61 . In the U.S.A., prevalence of self-referred '. As congestive heart failure is a serious health problem, a significant part of the health care burden falls upon the hospital system. In addition, the prognosis for congestive heart failure is poor. In the Framingham Heart Study, median survival was 1-7 years among males and 3-2 years among females, and survival at 5 years was 25% in males and 38% in females' 81 . Thus, hospitalization and mortality trends constitute a useful instrument for observing possible changes in the health care and demographic impact of congestive heart failure. Although population-based information on this topic is scanty in Europe, there is evidence of a 60% increase in hospital admissions for congestive heart failure in Scotland in the period 1980-199Q [9] Also, there has been an increase in hospitalizations for congestive heart failure in the U.S.A. in the last two decades'
10 "" 1 . This paper describes trends in hospitalization and mortality rates for congestive heart failure in Spain for the first time, covering the period 1980-1993. 
Methods
Hospitalization data were taken from the National Hospital Morbidity Survey conducted annually by the National Statistics Office (Instituto Nacional de Estadistica INE). This survey includes information on primary diagnosis for hospital admissions on a representative sample of Spanish hospitals, public (both civilian and military) and private. The overall sample size consisted of 75% of all Spanish hospitals and 10% of all patient admissions 1 ' 21 . Mortality data were taken from the National Vital Statistics database, as supplied by the INE. Only the underlying cause of death mentioned on the death certificate was considered.
For the purposes of this study, the following rubrics of the ninth revision of the International Classification of Diseases [l3] were deemed to constitute congestive heart failure: 398 (other acute rheumatic heart diseases), 402 (hypertensive heart disease), 404 (hypertensive heart and renal disease), 416 (chronic pulmonary heart disease), 425 (cardiomyopathy), 428 (heart failure), 429 (ill-defined descriptions and complications of heart disease).
The National Hospital Morbidity Survey does not track individuals; therefore the readmission to the hospital of the same person is counted as a separate event. As a consequence, hospital admissions refer to the number of cases admitted to a hospital. Admission rates relate this number to the population (in 100 000) of the country. Finally, hospital stays are the number of days spent in hospital as a consequence of a congestive heart failure admission.
Age-specific congestive heart failure hospitalization and mortality rates were calculated for persons aged >45 years, using population estimates furnished by the INE [I4 ' 151 . Lastly, age-adjusted rates were computed, using the direct method 1161 and the European population in 5-year age groups as standard' 171 .
Results

Hospitalizations
In 1980 there were 42 961 hospital admissions for congestive heart failure (23 255 in males and 19 706 in females). The number of admissions for congestive heart failure grew progessively until 1993, reaching a figure of 73 442 (35 101 in males and 38 341 in females) ( Table 1) . This represents an increase with respect to 1980 of 71-0% for both sexes, which breaks down as 50-9% in males and 94-6% in females. The percentage of first-time hospital admission for congestive heart failure over total hospital admissions for congestive heart failure remained stable during the period 1980-1993 (Table 1) .
Congestive heart failure hospitalization rates rose by 46-8%, going from 348-1 per 100 000 in 1980 to 511-0 per 100 000 in 1993, with men registering a 30-% and women a 68-5% rise (Table 1) . Whereas 58-1% of all hospital admissions for congestive heart failure involved persons aged >65 years in 1980, this figure had risen to 75-1% by 1993. The rise in the number and rate of admissions was limited to persons aged >65 years, and proved greater among women ( Fig. 1 (a) and (b), Table 2 ). Age-standardized congestive heart failure hospitalization rates rose by 26-4% for both sexes, which broke down as 26-9 in males and 36-4% in females for the period 1980-1993 ( Fig. 1  (c) ). The number of admissions for congestive heart failure was higher for women than men aged > 65 years ( Fig. 1 (a) , Table 2 ), due to the greater number of Spanish women in this age stratum. However, male congestive heart failure hospitalization rates remained Eur Heart J, Vol. 18, November 1997 18, November 1980 18, November 1981 18, November 1982 18, November 1983 18, November 1984 18, November 1985 18, November 1986 18, November 1987 18, November 1988 18, November 1989 18, November 1990 18, November 1991 18, November 1992 18, November 1993 Year 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 higher than those for women through the study period ( Fig. 1 (b) and (c), Table 2 ).
Cardiovascular diseases were the principal cause of hospitalization among the Spanish population aged >65 years in the period 1989-1993 (Table 3 ). In this age group and as between all cardiovascular diseases, congestive heart failure was the leading cause of hospitalization for both sexes and for women, and the second leading cause among men, immediately after ischaemic heart disease (ICD-9: 410-414). During the period 1989-1993, congestive heart failure accounted for 1 013 162 hospital stays per year, namely, 315 104 and 698 058 among persons in the 45-64 and >65 age groups respectively. In Spain, congestive heart failure, ischaemic heart disease and cerebrovascular disease (ICD-9: 430-438) hospitalization rates increased over the period 1980-1993 among men and women aged >65 years (Fig. 2) . Among the 45-64 age group, however only the ischaemic heart disease hospitalization rate rose (Fig. 2) . Congestive heart failure grew progressively less important compared to ischaemic heart disease as a cause of hospitalization among males in the period 1980-1993 (Fig. 2) .
Mortality
There were 29 190 congestive heart failure deaths (12 980 (Table 4 ). This represented a change with respect to 1980 of 16-5% for both sexes, which broke down as -2-0% in men and 31-3% in women. Although congestive heart failure mortality rates for both sexes registered no change between 1980 and 1993, they declined by -15-6% in men and rose by 13-6 in women (Table 4) .
In 1980, 83-1% of all congestive heart failure deaths occurred among persons aged >65 years, with this figure rising to 88-3% by 1993. All age groups registered a decline in the mortality rate except for the >80 age group, in which rates rose. Age-standardized congestive heart failure mortality rates declined by 23-0% (30-9% in males and 17-5% in females) from 1980 to 1993 (Fig. 3) . Male congestive heart failure mortality rates remained higher than those for women throughout the period.
The decrease in congestive heart failure mortality rates coincided with a moderate decline in ischaemic heart disease mortality and a marked fall in mortality due to cerebrovascular disease and cardiovascular causes as a whole (Fig. 4) . As a result, congestive heart failure continued to rank as the third leading cause of cardiovascular death in Spain. In the period 1989-1993, cardiovascular diseases accounted for 40-4% of all deaths in Spain, with congestive heart failure giving rise to 25-2% of cardiovascular deaths in persons aged >45 years.
Discussion
Congestive heart failure is the leading cause of hospitalization among persons aged >65 years in Spain. Furthermore, the congestive heart failure hospitalization rate rose substantially among persons aged >65 years during the period 1980-1993. Among the determinants of these results, there are both artificial and real factors. The most important artificial factor is that the Hospital Morbidity Survey database holds no information on congestive heart failure as secondary diagnosis on admission, or on patients who develop congestive heart failure postadmission and require treatment. Moreover, the coding of the grounds for hospital admission has improved substantially in Spain since the second half of the 1980s. This has led to the diagnosis of congestive heart failure being gradually replaced by other more specific diagnoses, such as ischaemic heart disease or other causes of congestive heart failure. Thus, while our results indeed show congestive heart failure to be an important public health problem, they underestimate the related hospital burden in Spain and the increase in same during the period 1980-1993.
Of the real factors responsible for the increase in congestive heart failure-related hospitalizations in Spain, probably the most important is the growth and ageing of the Spanish population during the study period. Whereas the 1981 population census put the number of persons aged >65 years at 4 236 724 (11-2% of the total population), the 1991 census reported a figure of 5 370 252 persons in this age group (13-8 of the total population) 118191 . The effect of these demographic factors can be seen in the increased steepness of the hospitalization slope when unadjusted for said factors ( Fig. 1 (a) vs (b) and (c) ). The rise in hospitalizations was rendered possible by the greater supply and accessibility of hospital services ensuing from the growth in the number of general hospitals 1201 and the improvement in means of transport in Spain that took place between 1980 and 1993.
The fact that hospitalizations increased solely among persons aged >65 years could, in part, be attributable to the decline in ischaemic heart disease' 211 and the generalization of antihypertensive treatments since the 1960s in Spain' 21>22) , thus displacing the appearance of congestive heart failure towards more advanced ages. It is additionally possible that the introduction of vasodilator- [4] and ACEI-based [5] treatments for congestive heart failure may have contributed to delaying hospitalizations until such ages. Lastly, as the percentage of first-time hospitalizations remained stable throughout the study period, the increase in the number of hospitalizations might be due to a rise both in congestive heart failure incidence and survival.
The health care burdens imposed by the principal cardiovascular disorders are a reflection of the respective frequencies of such disorders at different ages.
Ischaemic heart disease appears earlier and can be the cause of congestive heart failure and cerebrovascular disease. Accordingly, ischaemic heart disease generates a greater number of hospitalizations in the 45-64 age stratum, while congestive heart failure predominates in (b) Y e a r 2500 1980 1981 1982 1983 1984 1985 1986 1987 (c) Y e a r 100 1988 1989 1990 1991 1992 1993 < 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 Year the >65 age stratum (Table 2) . Attention should also be drawn to the considerable number of cerebrovascular disease-related hospitalizations, particularly among women aged >65 years (Table 2 ). In Spain, as in a number of Mediterranean countries, cerebrovascular disease is more frequent than ischaemic heart disease'
231
. This is consistent with the fact that in Spain, hypertension, the chief risk factor for cerebrovascular disease, is as frequently the cause of congestive heart failure, as is ischaemic heart disease . In Eur Heart J, Vol. 18, November 1997 1980 1981 1982 1983 1984 1985 1987 1988 1989 1990 1992 1993 Year 1980 1981 1982 1983 1984 1985 1987 1988 1989 1990 1992 1993 Year Scotland, however, the increase in hospitalizations was also reported for young adults and, in addition, the percentage of congestive heart failure admissions over total admissions at general and geriatric medical units grew in the period 1980-1990. In the U.S.A. on the other hand, the rise in hospitalizations in the period 1971-1990 basically affected the > 65-year age group. In both Scotland and the U.S.A., hospitalization rates were higher among men. Nevertheless, inter-country differences in coding practices and hospital-morbidity data sources hinder any comparison of hospitalization rates.
As regards congestive heart failure mortality, the most important finding was the reduction in ageadjusted rates for the period 1980-1993. It is feasible that part of the decline in congestive heart failure mortality might have been due to the decrease in ischaemic heart disease and, also, to the diagnosis of Eur Heart J, Vol. 18, November 1997 congestive heart failure being gradually replaced by the more specific diagnosis of ischaemic heart disease, as a result of improvements in diagnostic techniques and accessibility of health care services. However, the improvement in diagnosis and certification of cause of death would tend to affect persons aged > 80 years to a lesser extent. Despite the observed decline, congestive heart failure remained the third leading cause of cardiovascular death in Spain. Moreover, our data underestimate the demographic impact of congestive heart failure, because they included congestive heart failure only where it was the underlying cause of death. Regional studies into multiple causes of death suggest that congestive heart failure was mentioned on death certificates as contributory or secondary cause approximately 1-6 times more frequently than it was as the underlying cause (personal communication by Dr Antonio de Lucas).
Our results are consistent with those from Canada, where a decline in age-adjusted mortality was observed in both sexes in the period 1980-1989 [26) . In the U.S.A. however, a rise in congestive heart failure mortality was reported for the period 1980-1988, followed by a slight decline in 1989 and 1990 [ll>27) . It is possible that the decline in these last 2 years might be ascribable to the revision of the Standard Death Certificate in the U.S.A. in 1989 and the ensuing substitution of congestive heart failure by more specific causes of death 1 " 271 . Among the possible explanations for the differences in mortality trends between Spain, Canada and the U.S.A. in the period 1980-1988, is the different definition of congestive heart failure. In both ours and the Canadian analyses, as against that for the U.S.A., rubrics 402 and 404 were included. Mortality under rubrics 402 and 404 declined in the U.S.A. during the study period 1 " 1 . In Spain, however, the decrease in age-adjusted mortality in the period 1980-1993 remains at 24-9% (32-5% in men and 19-8% in women) when rubrics 402 and 404 are excluded from the analysis.
